FBQI4207-1 Farmacoquimica II

Re (1): Respecto del control N° 3 22 Sep 201722/09/17 at 12:002017-09-22 12:00:22

M. Pia Veronica Gaete
Respecto del control N° 3 22 Sep 201722/09/17 at 11:482017-09-22 11:48:22

Alejandro Álvarez L.
Re (3): Recalendarización Control 3 22 Sep 201722/09/17 at 11:382017-09-22 11:38:22

M. Pia Veronica Gaete
Re (2): Recalendarización Control 3 21 Sep 201721/09/17 at 19:562017-09-21 19:56:21

Fernando Guzmán G.
Re (1): Recalendarización Control 3 21 Sep 201721/09/17 at 17:362017-09-21 17:36:21

Camila Aguirre F.
Recalendarización Control 3 21 Sep 201721/09/17 at 15:562017-09-21 15:56:21

Alejandro Álvarez L.
anticancer 1, Septiembre 14, 2017a.pdf 14 Sep 201714/09/17 at 11:552017-09-14 11:55:14

Guillermo A. Diaz Araya
antivirales 7 Diciembre, 2017a.pdf 14 Sep 201714/09/17 at 11:522017-09-14 11:52:14

Guillermo A. Diaz Araya
control 2 6 Sep 201706/09/17 at 15:052017-09-06 15:05:06

Guillermo A. Diaz Araya
Re (11): Control 2 5 Sep 201705/09/17 at 17:382017-09-05 17:38:05

Camilo Soto
Re (10): Control 2 5 Sep 201705/09/17 at 16:552017-09-05 16:55:05

Juan Rodríguez M.
Re (9): Control 2 5 Sep 201705/09/17 at 13:192017-09-05 13:19:05

Ilse Macarena S. Pinares
Re (8): Control 2 5 Sep 201705/09/17 at 12:482017-09-05 12:48:05

Bárbara Pérez B.
Re (7): Control 2 5 Sep 201705/09/17 at 12:182017-09-05 12:18:05

Paulina A. Pérez
Re (6): Control 2 5 Sep 201705/09/17 at 12:172017-09-05 12:17:05

Camila Silva A.
Re (5): Control 2 5 Sep 201705/09/17 at 12:172017-09-05 12:17:05

Mariana Quiroga V.
Re (4): Control 2 5 Sep 201705/09/17 at 12:002017-09-05 12:00:05

Akemi Rivera Yonekura
Re (3): Control 2 5 Sep 201705/09/17 at 11:552017-09-05 11:55:05

Akemi Rivera Yonekura
Re (2): Control 2 5 Sep 201705/09/17 at 11:532017-09-05 11:53:05

Claudio Bli F.
Re (1): Control 2 5 Sep 201705/09/17 at 11:532017-09-05 11:53:05

Camila A. Díaz Urrutia
Control 2 5 Sep 201705/09/17 at 11:522017-09-05 11:52:05

Akemi Rivera Yonekura
Fármacos para las dislipidemias, Septiembre 2017.pdf 1 Sep 201701/09/17 at 09:372017-09-01 09:37:01

Guillermo A. Diaz Araya
antiarritmicos y vasodilatadores Agosto 2017.pdf 1 Sep 201701/09/17 at 09:342017-09-01 09:34:01

Guillermo A. Diaz Araya
Re (8): control 31 Aug 201731/08/17 at 00:462017-08-31 00:46:31

Luz Mora Fritz
Re (7): control 27 Aug 201727/08/17 at 22:402017-08-27 22:40:27

Camila Bravo J.

U-Cursos ::

FBQI4207-1 Farmacoquimica II 2017, Segundo Semestre

Farmacoquimica II

FBQI4207-1 - Segundo Semestre 2017

Historial

Re (1): Respecto del control N° 3 22 Sep 201722/09/17 at 12:002017-09-22 12:00:22

M. Pia Veronica Gaete

Respecto del control N° 3 22 Sep 201722/09/17 at 11:482017-09-22 11:48:22

Alejandro Álvarez L.

Re (3): Recalendarización Control 3 22 Sep 201722/09/17 at 11:382017-09-22 11:38:22

M. Pia Veronica Gaete

Re (2): Recalendarización Control 3 21 Sep 201721/09/17 at 19:562017-09-21 19:56:21

Fernando Guzmán G.

Re (1): Recalendarización Control 3 21 Sep 201721/09/17 at 17:362017-09-21 17:36:21

Camila Aguirre F.

Recalendarización Control 3 21 Sep 201721/09/17 at 15:562017-09-21 15:56:21

Alejandro Álvarez L.

anticancer 1, Septiembre 14, 2017a.pdf 14 Sep 201714/09/17 at 11:552017-09-14 11:55:14

Guillermo A. Diaz Araya

antivirales 7 Diciembre, 2017a.pdf 14 Sep 201714/09/17 at 11:522017-09-14 11:52:14

Guillermo A. Diaz Araya

control 2 6 Sep 201706/09/17 at 15:052017-09-06 15:05:06

Guillermo A. Diaz Araya

Re (11): Control 2 5 Sep 201705/09/17 at 17:382017-09-05 17:38:05

Camilo Soto

Re (10): Control 2 5 Sep 201705/09/17 at 16:552017-09-05 16:55:05

Juan Rodríguez M.

Re (9): Control 2 5 Sep 201705/09/17 at 13:192017-09-05 13:19:05

Ilse Macarena S. Pinares

Re (8): Control 2 5 Sep 201705/09/17 at 12:482017-09-05 12:48:05

Bárbara Pérez B.

Re (7): Control 2 5 Sep 201705/09/17 at 12:182017-09-05 12:18:05

Paulina A. Pérez

Re (6): Control 2 5 Sep 201705/09/17 at 12:172017-09-05 12:17:05

Camila Silva A.

Re (5): Control 2 5 Sep 201705/09/17 at 12:172017-09-05 12:17:05

Mariana Quiroga V.

Re (4): Control 2 5 Sep 201705/09/17 at 12:002017-09-05 12:00:05

Akemi Rivera Yonekura

Re (3): Control 2 5 Sep 201705/09/17 at 11:552017-09-05 11:55:05

Akemi Rivera Yonekura

Re (2): Control 2 5 Sep 201705/09/17 at 11:532017-09-05 11:53:05

Claudio Bli F.

Re (1): Control 2 5 Sep 201705/09/17 at 11:532017-09-05 11:53:05

Camila A. Díaz Urrutia

Control 2 5 Sep 201705/09/17 at 11:522017-09-05 11:52:05

Akemi Rivera Yonekura

Fármacos para las dislipidemias, Septiembre 2017.pdf 1 Sep 201701/09/17 at 09:372017-09-01 09:37:01

Guillermo A. Diaz Araya

antiarritmicos y vasodilatadores Agosto 2017.pdf 1 Sep 201701/09/17 at 09:342017-09-01 09:34:01

Guillermo A. Diaz Araya

Re (8): control 31 Aug 201731/08/17 at 00:462017-08-31 00:46:31

Luz Mora Fritz

Re (7): control 27 Aug 201727/08/17 at 22:402017-08-27 22:40:27

Camila Bravo J.